JPH07121939B2 - 窒素含有４または５員複素環で置換されたイミダゾリルまたはイミダゾイルアルキル化合物 - Google Patents

窒素含有４または５員複素環で置換されたイミダゾリルまたはイミダゾイルアルキル化合物

Info

Publication number
JPH07121939B2
JPH07121939B2 JP5511100A JP51110093A JPH07121939B2 JP H07121939 B2 JPH07121939 B2 JP H07121939B2 JP 5511100 A JP5511100 A JP 5511100A JP 51110093 A JP51110093 A JP 51110093A JP H07121939 B2 JPH07121939 B2 JP H07121939B2
Authority
JP
Japan
Prior art keywords
compound
alkyl
organic solvent
benzyl
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP5511100A
Other languages
English (en)
Japanese (ja)
Other versions
JPH06511009A (ja
Inventor
シー，ネン−ヤン
アスラニアン，ロバート
ルポ，アンドリュー，ジュニアー
ピウィンスキー，ジョン・ジェイ
グリーン，マイケル・ジェイ
ギャングリー，アシット・ケイ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Schering Plough Corp
Original Assignee
Schering Corp
Schering Plough Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp, Schering Plough Corp filed Critical Schering Corp
Publication of JPH06511009A publication Critical patent/JPH06511009A/ja
Publication of JPH07121939B2 publication Critical patent/JPH07121939B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP5511100A 1991-12-18 1992-12-17 窒素含有４または５員複素環で置換されたイミダゾリルまたはイミダゾイルアルキル化合物 Expired - Fee Related JPH07121939B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US80978191A 1991-12-18 1991-12-18
US809781 1991-12-18
PCT/US1992/010743 WO1993012108A1 (en) 1991-12-18 1992-12-17 Imidazolyl or imidazoylalkyl substituted with a four or five membered nitrogen containing heterocyclic ring

Publications (2)

Publication Number Publication Date
JPH06511009A JPH06511009A (ja) 1994-12-08
JPH07121939B2 true JPH07121939B2 (ja) 1995-12-25

Family

ID=25202205

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5511100A Expired - Fee Related JPH07121939B2 (ja) 1991-12-18 1992-12-17 窒素含有４または５員複素環で置換されたイミダゾリルまたはイミダゾイルアルキル化合物

Country Status (20)

Country Link
US (1) US5463074A (enExample)
EP (1) EP0618913B1 (enExample)
JP (1) JPH07121939B2 (enExample)
KR (1) KR0142802B1 (enExample)
AT (1) ATE141269T1 (enExample)
AU (1) AU671092B2 (enExample)
CA (1) CA2129679C (enExample)
DE (1) DE69212844T2 (enExample)
DK (1) DK0618913T3 (enExample)
ES (1) ES2090956T3 (enExample)
GR (1) GR3021464T3 (enExample)
HK (1) HK31397A (enExample)
IL (1) IL104125A (enExample)
MX (1) MX9207393A (enExample)
MY (1) MY110108A (enExample)
NZ (1) NZ246441A (enExample)
SG (1) SG44510A1 (enExample)
TW (1) TW268950B (enExample)
WO (1) WO1993012108A1 (enExample)
ZA (1) ZA929788B (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5633250A (en) * 1991-12-18 1997-05-27 Schering Corporation Imidazoylalkyl substituted with a six or seven membered heterocyclic ring containing two nitrogen atoms
FR2732017B1 (fr) * 1995-03-21 2000-09-22 Inst Nat Sante Rech Med Nouveaux derives de l'imidazole antagonistes et/ou agonistes du recepteur h3 de l'histamine, leur preparation et leurs applications therapeutiques
WO1997001556A1 (en) * 1995-06-29 1997-01-16 Novo Nordisk A/S Novel substituted azacyclic or azabicyclic compounds
AU715603B2 (en) * 1996-04-03 2000-02-03 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
EP0891352A4 (en) * 1996-04-03 2001-08-16 Merck & Co Inc INHIBITORS OF FARNESYL PROTEIN TRANSFERASE
US6072057A (en) * 1996-06-06 2000-06-06 Gliatech Inc. 1H-4(5)-cyclo-substituted imidazole derivatives as histamine H3 receptor agents
US6407132B1 (en) 1997-07-25 2002-06-18 James Black Foundation Limited Substituted imidazole derivatives and their use as histamine H3 receptor ligands
KR20010031839A (ko) * 1997-11-07 2001-04-16 둘락 노먼 씨. 한 개의 질소원자를 함유하는 5, 6 또는 7원헤테로사이클릭 환으로 치환된 이미다조일알킬
US6034251A (en) * 1997-11-07 2000-03-07 Schering Corporation Phenyl-alkyl-imidazoles
US5990147A (en) * 1997-11-07 1999-11-23 Schering Corporation H3 receptor ligands of the phenyl-alkyl-imidazoles type
US6028095A (en) * 1998-10-15 2000-02-22 Warner-Lambert Company Treatment of inflammatory bowel disease using histamine H3 -receptor agonists
US6133291A (en) * 1998-10-16 2000-10-17 Schering Corporation N-(imidazolylalkyl)substituted cyclic amines as histamine-H3 agonists or antagonists
US6100279A (en) * 1998-11-05 2000-08-08 Schering Corporation Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom
WO2000042023A1 (en) 1999-01-18 2000-07-20 Novo Nordisk A/S Substituted imidazoles, their preparation and use
US6908926B1 (en) 1999-04-16 2005-06-21 Novo Nordisk A/S Substituted imidazoles, their preparation and use
GB9924941D0 (en) * 1999-10-22 1999-12-22 Univ Manchester Treatment of dyskinesia
US6610721B2 (en) 2000-03-17 2003-08-26 Novo Nordisk A/S Imidazo heterocyclic compounds
US6437147B1 (en) 2000-03-17 2002-08-20 Novo Nordisk Imidazole compounds
PE20020507A1 (es) 2000-10-17 2002-06-25 Schering Corp Compuestos no-imidazoles como antagonistas del receptor histamina h3
JP2004529117A (ja) 2001-02-08 2004-09-24 シェーリング　コーポレイション 認知欠陥障害の処置における二重のｈ３／ｍ２アンタゴニストの使用
MXPA03008356A (es) 2001-03-13 2003-12-11 Schering Corp Compuestos del tipo no imidazol como antagonistas de histamina h3.
FR2827863A1 (fr) * 2001-07-27 2003-01-31 Sanofi Synthelabo Derives d'aminoalkylimidazole, leur preparation et leur utilisation en therapeutique
US7332508B2 (en) * 2002-12-18 2008-02-19 Novo Nordisk A/S Substituted homopiperidine, piperidine or pyrrolidine derivatives
GB0505969D0 (en) 2005-03-23 2005-04-27 Novartis Ag Organic compounds
EP1707203A1 (en) 2005-04-01 2006-10-04 Bioprojet Treatment of parkinson's disease obstructive sleep apnea, dementia with lewy bodies, vascular dementia with non-imidazole alkylamines histamine H3- receptor ligands
EP1717233A1 (en) * 2005-04-29 2006-11-02 Bioprojet Histamine H3-receptor ligands and their therapeutic application
EP1717235A3 (en) 2005-04-29 2007-02-28 Bioprojet Phenoxypropylpiperidines and -pyrrolidines and their use as histamine H3-receptor ligands
GB0514203D0 (en) 2005-07-11 2005-08-17 Novartis Ag Organic compounds
EP1968940B1 (en) 2005-12-30 2014-04-02 Novartis AG 3 , 5-substitued piperidine compounds as renin inhibitors
NZ582098A (en) 2007-06-25 2012-03-30 Novartis Ag N5-(2-ethoxyethyl)-n3-(2-pyridinyl)-3,5-piperidinedicarboxamide derivatives for use as renin inhibitors
WO2013151982A1 (en) 2012-04-03 2013-10-10 Arena Pharmaceuticals, Inc. Methods and compounds useful in treating pruritus, and methods for identifying such compounds

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2987522A (en) * 1958-03-17 1961-06-06 Petrolite Corp Amidine products
US3491098A (en) * 1967-05-29 1970-01-20 Sterling Drug Inc 1-((imidazolyl)-lower-alkyl)-4-substituted-piperazines
US3470197A (en) * 1967-08-30 1969-09-30 Miles Lab 1-substituted derivatives of 3-ethyl-4 - (1-methylimidazolyl-(5)-methyl)-2-pyrrolidinone
US4011238A (en) * 1972-07-26 1977-03-08 Gruppo Lepetit S.P.A. 2-imidazolidione derivatives
EP0003732B1 (en) * 1978-02-01 1983-10-19 The Wellcome Foundation Limited Imidazole derivatives and salts thereof, their synthesis, and pharmaceutical formulations thereof
GR73560B (enExample) * 1979-02-24 1984-03-15 Pfizer
DK151884C (da) * 1979-03-07 1988-06-13 Pfizer Analogifremgangsmaade til fremstilling af 3-(1-imidazolylalkyl)indolderivater eller farmaceutisk acceptable syreadditionssalte deraf
US4404387A (en) * 1980-09-17 1983-09-13 The Upjohn Company Aminoalkyl-substituted imidazoles
US4404382A (en) * 1980-09-17 1983-09-13 The Upjohn Company Piperazinyl-substituted imidazoles
US4431653A (en) * 1982-03-18 1984-02-14 Hoffmann-La Roche Inc. Penicillanic acid derivatives
DE3313073A1 (de) * 1983-04-12 1984-10-18 Bayer Ag, 5090 Leverkusen 1-azolyl-3-pyrazolyl-2-propanol-derivate, verfahren zu ihrer herstellung und ihre verwendung als fungizide
US4581370A (en) * 1983-07-12 1986-04-08 Schering A.G. Antiarrhythmic imidazoliums
DK704488D0 (da) * 1988-12-19 1988-12-19 Novo Industri As Nye n-substituerede azaheterocykliske carboxylsyrer
FR2579596B1 (fr) * 1985-03-26 1987-11-20 Inst Nat Sante Rech Med (imidazolyl-4) piperidines, leur preparation et leur application en therapeutique
FR2586562B1 (fr) * 1985-09-02 1989-03-10 Inst Nat Sante Rech Med Composition pharmaceutique contenant de l'a-methylhistamine
US5091428A (en) * 1987-04-24 1992-02-25 Syntex Pharmaceuticals, Ltd. Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives
US5010075A (en) * 1987-04-24 1991-04-23 Syntex Pharmaceuticals Ltd. Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives
US4935417A (en) * 1987-04-24 1990-06-19 Syntex Pharmaceuticals Ltd. Sustituted imidazolyl-alkyl-piperazine and -diazepine derivatives for treating cerebrovascular disease
DE3811574A1 (de) * 1988-03-31 1989-10-19 Schering Ag N-substituierte imidazole, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
FR2630328B1 (fr) * 1988-04-22 1990-08-24 Inst Nat Sante Rech Med Derive de l'histamine, sa preparation et son application en therapeutique
US4925851A (en) * 1989-05-23 1990-05-15 Sandoz Pharmaceuticals Corp. 2- or 4-substituted-[2-(1H-imidazol-1-yl)ethyl]piperidines
US5264449A (en) * 1989-11-13 1993-11-23 Allergan, Inc. N-substituted derivatives of 3R,4R-ethyl-[(1-methyl-1H-imidazol-5-yl)methyl]-2-pyrrolidinone
US5066663A (en) * 1990-05-21 1991-11-19 Warner-Lambert Company Substituted-hetero-cyclopentanones and cyclopentenones and derivatives thereof acting at muscarinic receptors
WO1993020061A1 (en) * 1992-04-01 1993-10-14 The University Of Toledo 4-[4'-piperidinyl or 3'-pirrolidinyl] substituted imidazoles as h3-receptor antagonists and therapeutic uses thereof

Also Published As

Publication number Publication date
MY110108A (en) 1998-01-27
DK0618913T3 (da) 1996-10-14
EP0618913A1 (en) 1994-10-12
CA2129679A1 (en) 1993-06-24
DE69212844D1 (de) 1996-09-19
US5463074A (en) 1995-10-31
JPH06511009A (ja) 1994-12-08
TW268950B (enExample) 1996-01-21
MX9207393A (es) 1994-06-30
ZA929788B (en) 1993-06-22
GR3021464T3 (en) 1997-01-31
NZ246441A (en) 1996-02-27
DE69212844T2 (de) 1997-01-09
HK31397A (en) 1997-03-21
ATE141269T1 (de) 1996-08-15
IL104125A (en) 2000-08-31
EP0618913B1 (en) 1996-08-14
ES2090956T3 (es) 1996-10-16
IL104125A0 (en) 1993-05-13
KR940703826A (enExample) 1994-12-12
AU3277393A (en) 1993-07-19
AU671092B2 (en) 1996-08-15
SG44510A1 (en) 1997-12-19
CA2129679C (en) 2000-05-09
WO1993012108A1 (en) 1993-06-24
KR0142802B1 (en) 1998-07-15

Similar Documents

Publication Publication Date Title
JPH07121939B2 (ja) 窒素含有４または５員複素環で置換されたイミダゾリルまたはイミダゾイルアルキル化合物
EP0619818B1 (en) Imidazoylalkyl substituted with a six membered nitrogen containing heterocyclic ring
EP0613458B1 (en) Acyclic ethylenediamine derivatives as substance p receptor antagonists
JP2514137B2 (ja) キヌクリジン誘導体
JP2535134B2 (ja) 縮合三環式窒素含有複素環
CA2209640C (en) Cycloalkano-pyridines
US5356905A (en) Neuroprotective 3-piperidino-4-hydroxychroman derivatives and analogs
AU662588B2 (en) Imidazolyl-alkyl-piperazine and -diazepine derivatives as histamine H3 agonists/antagonists
JPH0578354A (ja) アザ二環式化合物、これを含有する医薬組成物及び治療のための使用方法
US4968678A (en) Tetrazole excitatory amino acid receptor antagonists
JPH07509727A (ja) Ｃｒｆアンタゴニスト活性を有するアミノ置換ピラゾール
JPH07508993A (ja) アザサイクリック化合物
JPH082901B2 (ja) １−アザビシクロ［３．２．２ノナン−３−アミン誘導体類
AU716435B2 (en) Novel indole-2,3-dione-3-oxime derivatives
EP1984002B1 (en) Trialkylsilylbenzylaminocarboxyindoles, indazoles and indolines and their use in treating cetp-mediated disorders
US5498610A (en) Neuroprotective indolone and related derivatives
KR19990028918A (ko) 헤테로시클릴카르복스아미드 유도체 및 치료제로서의 그들의 용도
US5712288A (en) Quaternary basic amides, method of preparing them and pharmaceutical compositions in which they are present
US5807872A (en) Imidazoylalkyl substituted with a six membered nitrogen containing heterocyclic ring
EP0362941A2 (en) 4-Methyl and 4-ethyl substituted pyrrolidin-2-ones
US5302716A (en) Fused benzazepines
JPH06312989A (ja) （１ｒｓ，２ｒｓ，４ｓｒ）−２−（６−クロロ−３−ピリジル）−７−アザビシクロ［２．２．１］ヘプタンの製造方法
US5932596A (en) Imidazoylalkyl substituted with a six membered nitrogen containing nitrogen containing heterocyclic ring
JPH08503955A (ja) 治療に有用なフラノン誘導体
JP2005501041A (ja) 抗精神病活性を有する、２−（アミノメチル）−テトラヒドロ−９−オキサ−１，３−ジアザ−シクロペンタ［ａ］ナフタレニル誘導体

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees